SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-061268
Filing Date
2018-10-10
Accepted
2018-10-10 08:38:27
Documents
3
Period of Report
2018-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36513_18k.htm 8-K 32347
2 EX-99.1 a18-36513_1ex99d1.htm EX-99.1 16388
3 GRAPHIC g365131mmi001.jpg GRAPHIC 2854
  Complete submission text file 0001104659-18-061268.txt   54147
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 181114922
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1